158
Views
1
CrossRef citations to date
0
Altmetric
Notes

A new ent-kaurane diterpenoid from the pericarps of Datura metel

, , , , , ORCID Icon, , , & show all
Pages 884-890 | Received 06 Mar 2021, Accepted 13 Sep 2021, Published online: 14 Oct 2021
 

Abstract

A new ent-kaurane diterpenoid, named kaurane daturoside A (1), was isolated from the 70%-EtOH extract of dried pericarps of Datura metel L., along with six known terpenoids, 16α,17-dihydroxy-ent-kauran-19-diglycoside (2), cyclosieversioside F (3), astragaloside II (4), ginsenoside Rg1 (5), astrojanoside A (6), celerioside E (7). The isolated structures were elucidated by means of spectroscopic analyses, and the compounds 2, 3, 7 were separated from Solanaceae for the first time. Meanwhile, among isolates, compounds 2 and 5 exhibited anti-inflammatory activities against LPS-activated RAW264.7 cells (IC50<11.00 μM).

Graphical Abstract

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This research work was financially supported by the National Natural Science Foundation of China (NSFC) (81773883, 81903781); National Key Research and Development Project (2018YFC1707100); China Postdoctoral Science Foundation (2018M631978); Excellent Youth Project of Heilongjiang Natural Science Foundation (YQ2019H029); Heilongjiang University of Chinese Medicine Founds (2018pt01, 2018bs03); Innovative Research Project for graduate students of Heilongjiang University of Chinese Medicine (2020yjscx009).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.